Hippocampal BDNF expression in a Tau transgenic mouse model

Current Alzheimer Research

Volumn 9, Issue 4, 2012, Pages 406-410

  Burnouf, Sylvie ^a,b,c,d   Belarbi, Karim ^a,b,c   Troquier, Laetitia ^a,b   Derisbourg, Maxime ^a,b   Demeyer, Dominique ^a,b   Leboucher, Antoine ^a,b   Laurent, Cyril ^a,b   Hamdane, Malika ^a,b   Buée, Luc ^a,b,c   Blum, David ^a,b,c  

^a UNIV LILLE   (France)

^b JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d MAX PLANCK INSTITUTE FOR BIOLOGY OF AGEING   (Germany)

Author keywords

Alzheimer's disease; BDNF; Neurotrophins; Tau; Tauopathies; Transgenic models

Indexed keywords

AMYLOID PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; PRO BRAIN DERIVED NEUROTROPHIC FACTOR; PROTEIN PRECURSOR; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; GENE EXPRESSION; GROUPS BY AGE; HIPPOCAMPUS; HOMEOSTASIS; MALE; MEMORY DISORDER; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TAUOPATHY; TRANSGENIC MOUSE; UPREGULATION; WESTERN BLOTTING;

EID: 84860500322     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720512800492468     Document Type: Article

References (45)

1. Duyckaerts C, Bennecib M, Grignon Y, Uchihara T, He Y, Plette F, et al. Modeling the relation between neurofibrillary tangles and intellectual status. Neurobiol Aging 18: 267-73 (1997).
2. Grober E, Dickson D, Sliwinski MJ, Buschke H, Katz M, Crystal H, et al. Memory and mental status correlates of modified Braak staging. Neurobiol Aging 20: 573-9 (1999).
3. Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 16: 271-8; discussion 8-84 (1995).
4. Delacourte A, David JP, Sergeant N, et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52: 1158-65 (1999).
5. Ernfors P, Ibanez CF, Ebendal T, Olson L, Persson H. Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci USA 87: 5454-8 (1990).
6. Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 9: 2459-64 (1990).
7. Blum R, Konnerth A. Neurotrophin-mediated rapid signaling in the central nervous system: mechanisms and functions. Physiology (Bethesda) 20: 70-8 (2005).
8. Cirulli F, Berry A, Chiarotti F, Alleva E. Intrahippocampal administration of BDNF in adult rats affects short-term behavioral plasticity in the Morris water maze and performance in the elevated plus-maze. Hippocampus 14: 802-7 (2004).
9. Mu JS, Li WP, Yao ZB, Zhou XF. Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats. Brain Res 835: 259-65 (1999).
10. Mizuno M, Yamada K, Olariu A, Nawa H, Nabeshima T. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. J Neurosci 20: 7116-21 (2000).
11. Heldt SA, Stanek L, Chhatwal JP, Ressler KJ. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 12: 656-70 (2007).
12. Neeper SA, Gomez-Pinilla F, Choi J, Cotman CW. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 726: 49-56 (1996).
13. Griffin EW, Bechara RG, Birch AM, Kelly AM. Exercise enhances hippocampal-dependent learning in the rat: evidence for a BDNFrelated mechanism. Hippocampus 19: 973-80 (2009).
14. Belarbi K, Burnouf S, Fernandez-Gomez FJ, Laurent C, Lestavel S, Figeac M, et al. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology. Neurobiol Dis 43: 486-94 (2011).
15. Ickes BR, Pham TM, Sanders LA, Albeck DS, Mohammed AH, Granholm AC. Long-term environmental enrichment leads to regional increases in neurotrophin levels in rat brain. Exp Neurol 164: 45-52 (2000).
16. Branchi I, D'Andrea I, Fiore M, Di Fausto V, Aloe L, Alleva E. Early social enrichment shapes social behavior and nerve growth factor and brain-derived neurotrophic factor levels in the adult mouse brain. Biol Psychiatry 60: 690-6 (2006).
17. Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15: 1768-77 (1995).
18. Castren E, Voikar V, Rantamaki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol 7: 18-21 (2007).
19. Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 45: 104-14 (2004).
20. Fahnestock M, Garzon D, Holsinger RM, Michalski B. Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule? J Neural Transm Suppl 241-52 (2002).
21. Ferrer I, Marin C, Rey MJ, Ribalta T, Goutan E, Blanco R, et al. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol 58: 729-39 (1999).
22. Schindowski K, Belarbi K, Buee L. Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav(7 Suppl 1): 43-56 (2008).
23. Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev 59: 201-20 (2008).
24. Garzon DJ, Fahnestock M. Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J Neurosci 27: 2628-35 (2007).
25. Peng S, Garzon DJ, Marchese M, Klein W, Ginsberg SD, Francis BM, et al. Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. J Neurosci 29: 9321-9 (2009).
26. Poon WW, Blurton-Jones M, Tu CH, Feinberg LM, Chabrier NA, Harris JW, et al. beta-Amyloid impairs axonal BDNF retrograde trafficking. Neurobiol Aging 32: 821-33 (2011).
27. Schindowski K, Bretteville A, Leroy K, Begard S, Brion JP, Hamdane M, et al. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol 169: 599-616 (2006).
28. Belarbi K, Schindowski K, Burnouf S, Caillierez R, Grosjean ME, Demeyer D, et al. Early Tau pathology involving the septohippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease. Curr Alzheimer Res 6: 152-7 (2009).
29. Belarbi K, Burnouf S, Fernandez-Gomez FJ, Desmereieres J, Troquier L, Brouillette J, et al. Loss of Medial Septum Cholinergic Neurons in THY-Tau22 Mouse Model: What Links with Tau Pathology? Curr Alzheimer Res 8: (2011).
30. Van der Jeugd A, Ahmed T, Burnouf S, Belarbi K, Hamadame M, Grosjean ME, et al. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Neurobiol Learn Mem 95: 296-304 (2011).
31. Szapacs ME, Numis AL, Andrews AM. Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1. Neurobiol Dis 16: 572-80 (2004).
32. Ferrer I, Marin C, Rey MJ, Ribalta T. Brain-derived neurotrophic factor in patients with frontotemporal dementia. Neurosci Lett 279: 33-6 (2000).
33. Greenberg ME, Xu B, Lu B, Hempstead BL. New insights in the biology of BDNF synthesis and release: implications in CNS function. J Neurosci 29: 12764-7 (2009).
34. Hill RA, Murray SS, Halley PG, Binder MD, Martin SJ, van den Buuse M. Brain-derived neurotrophic factor expression is increased in the hippocampus of 5-HT(2C) receptor knockout mice. Hippocampus 21: 434-45 (2011).
35. Medina MG, Ledesma MD, Dominguez JE, Medina M, Zafra D, Alameda F, et al. Tissue plasminogen activator mediates amyloidinduced neurotoxicity via Erk1/2 activation. EMBO J 24: 1706-16 (2005).
36. Gorski JA, Balogh SA, Wehner JM, Jones KR. Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice. Neuroscience 121: 341-54 (2003).
37. Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castella Na, Muller FJ, Loning JF, et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci USA 106: 13594-9 (2009).
38. Nagahara AH, Merrill DA, Coppola G, Tsukadr S, Schroeder BE, Shaked GM, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 15: 331-7 (2009).
39. Caccamo A, Maldonado MA, Bokov AF, Majumder S, Oddo S. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 107: 22687-92 (2010).
40. Adlard PA, Perreau VM, Pop V, Cotman CW. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci 25: 4217-21 (2005).
41. Hopkins ME, Bucci DJ, Buee L, Waltez A, Vermersch P, et al. BDNF expression in perirhinal cortex is associated with exerciseinduced improvement in object recognition memory. Neurobiol Learn Mem (2010).
42. Khabour OF, Alzoubi KH, Alomari MA, Alzubi MA. Changes in spatial memory and BDNF expression to concurrent dietary restriction and voluntary exercise. Hippocampus 20: 637-45 (2010).
43. Cunha C, Angelucci A, D'Antoni A, Dobrossy MD, Dunnett SB, Berardi N, et al. Brain-derived neurotrophic factor (BDNF) overexpression in the forebrain results in learning and memory impairments. Neurobiol Dis 33: 358-68 (2009).
44. Croll SD, Suri C, Compton DL, Simmoins MV, Yancopoulos GD, Lindsay RM, et al. Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience 93: 1491-506 (1999).
45. Papaleo F, Silverman JL, Aney J, Tian Q, Barkan CL, Chadman KK, et al. Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice. Learn Mem 18: 534-44 (2011).